Last reviewed · How we verify
NCT03923244: C-SS0
Dry Eye Syndrome Description During Cataract Surgery, With Multimodal Analysis of the Ocular Surface
NA trial testing OSDI survey in Dry Eye Syndrome in 100 participants. Completed in 6 March 2020.
6 March 2020
Quick facts
| Lead sponsor | University Hospital, Clermont-Ferrand |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 100 |
| Start date | 1 April 2019 |
| Primary completion | 6 March 2020 |
| Estimated completion | 6 March 2020 |
| Sites | 1 location across France |
Drugs / interventions tested
- OSDI survey
Conditions studied
- Dry Eye Syndrome — all drugs for Dry Eye Syndrome →
- Ocular Surface Disease — all drugs for Ocular Surface Disease →
Sponsor
University Hospital, Clermont-Ferrand
Who can join
18 and older, any sex, with Dry Eye Syndrome or Ocular Surface Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective is to describe the characteristics of dry eye syndrome before and after surgery at one month of cataract surgery, using a multimodal analysis of the ocular surface. The secondary objectives are to evaluate: * Predictive factors of dry eye syndrome during cataract surgery: * The characteristics of dry eye syndrome * Implications for the patient's quality of life
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03923244
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dry Eye Syndrome
Currently open trials in the same condition.
- NCT07295691 — Autologous Serum Eye Drops in Dry Eye Syndrome · NA · recruiting
- NCT06914232 — Efficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative DES · NA · active not recruiting
- NCT06913556 — Comparing Effect of Hylorunic Acid and Lipid-coated Carbomer Gel on Dry Eyes After Phacoemulsification in DP · NA · active not recruiting
Other University Hospital, Clermont-Ferrand trials
Trials by the same sponsor.
- NCT07179276 — Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock · NA · recruiting
- NCT07476768 — PAINDYS_Characterizing Pain in Fibrous Dysplasia of Bone/McCune-Albright Syndrome: an Exploratory Pilot Study · NA · not yet recruiting
- NCT07439146 — Risk of Pneumonia in Intubated Patients in Emergency Situations · not yet recruiting
- NCT07427537 — Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients · NA · recruiting
- NCT07330856 — Evaluation of Treatments for Dry or Productive Cough · Phase 4 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03923244 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Clermont-Ferrand
- Last refreshed: 24 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03923244.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing